Orencia (abatacept intravenous infusion) — Cigna

Initial criteria

• Patient age > 18 years; AND
• Medication is prescribed by or in consultation with a rheumatologist or a dermatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months; AND
• Patient meets at least ONE of the following: (a) When assessed by at least one objective measure, patient experienced a beneficial clinical response from baseline; OR (b) Compared with baseline, patient experienced improvement in at least one symptom (e.g., less joint pain, morning stiffness, fatigue, improved function, activities of daily living, decreased joint or tendon swelling)

Approval duration

initial 6 months, reauthorization 1 year